Literature DB >> 9271240

Continuous hepatocyte growth factor supply prevents lipopolysaccharide-induced liver injury in rats.

T Kaido1, S Yamaoka, S Seto, N Funaki, T Kasamatsu, J Tanaka, T Nakamura, M Imamura.   

Abstract

We present a rat model in which continuous supply of hepatocyte growth factor (HGF) prevents liver injury induced by carbon tetrachloride (CCl4) and E. coli 011:B4 lipopolysaccharide (LPS). Rat fibroblasts genetically modified to secrete rat HGF were implanted in syngenic rat spleen 7 days before administration of the hepatotoxins. Rats with HGF-secreting fibroblasts in the spleen showed a dramatic resistance to CCl4- and LPS-induced liver injury. In the LPS-induced liver injury model, blood chemical analysis revealed that the increase in serum glutamic oxalacetic transaminase level and the decrease in blood sugar level were remarkably suppressed in rats with HGF-secreting cells in the spleen. Most importantly, their survival rate was greatly improved compared to other control groups of rats. Thus our results indicate a new role of HGF in liver protection during endotoxemia and convey important clinical implications for developing new therapeutic modalities in the treatment of liver failure caused by endotoxemia.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9271240     DOI: 10.1016/s0014-5793(97)00744-8

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  9 in total

Review 1.  Gene therapy for liver regeneration: experimental studies and prospects for clinical trials.

Authors:  Hussein-M Atta
Journal:  World J Gastroenterol       Date:  2010-08-28       Impact factor: 5.742

2.  Novel role for endogenous hepatocyte growth factor in the pathogenesis of intracranial aneurysms.

Authors:  Ricardo A Peña-Silva; Nohra Chalouhi; Lauren Wegman-Points; Muhammad Ali; Ian Mitchell; Gary L Pierce; Yi Chu; Zuhair K Ballas; Donald Heistad; David Hasan
Journal:  Hypertension       Date:  2014-12-15       Impact factor: 10.190

3.  Serum hyaluronate level for predicting subclinical liver dysfunction after hepatectomy.

Authors:  Toru Mizuguchi; Tadashi Katsuramaki; Takayuki Nobuoka; Masaki Kawamoto; Hideki Oshima; Hiroyuki Kawasaki; Hitoshi Kikuchi; Chihiro Shibata; Koichi Hirata
Journal:  World J Surg       Date:  2004-09-29       Impact factor: 3.352

4.  Improvement of sepsis by hepatocyte growth factor, an anti-inflammatory regulator: emerging insights and therapeutic potential.

Authors:  Shinya Mizuno; Toshikazu Nakamura
Journal:  Gastroenterol Res Pract       Date:  2012-02-28       Impact factor: 2.260

5.  Synthesis of IL-6 by hepatocytes is a normal response to common hepatic stimuli.

Authors:  Callie A Norris; Mu He; Liang-I Kang; Michael Qi Ding; Josiah E Radder; Meagan M Haynes; Yu Yang; Shirish Paranjpe; William C Bowen; Anne Orr; George K Michalopoulos; Donna B Stolz; Wendy M Mars
Journal:  PLoS One       Date:  2014-04-24       Impact factor: 3.240

6.  Quantitative proteomic analysis of hepatocyte-secreted extracellular vesicles reveals candidate markers for liver toxicity.

Authors:  Eva Rodríguez-Suárez; Esperanza Gonzalez; Chris Hughes; Javier Conde-Vancells; Andrea Rudella; Felix Royo; Laura Palomo; Felix Elortza; Shelly C Lu; Jose M Mato; Johannes P C Vissers; Juan M Falcón-Pérez
Journal:  J Proteomics       Date:  2014-04-18       Impact factor: 4.044

7.  HGF mediates the anti-inflammatory effects of PRP on injured tendons.

Authors:  Jianying Zhang; Kellie K Middleton; Freddie H Fu; Hee-Jeong Im; James H-C Wang
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

8.  Effects of platelet-rich plasma and triamcinolone acetonide on interleukin-1ß-stimulated human rotator cuff-derived cells.

Authors:  T Muto; T Kokubu; Y Mifune; A Inui; R Sakata; Y Harada; F Takase; M Kurosaka
Journal:  Bone Joint Res       Date:  2016-12       Impact factor: 5.853

9.  Yi Guan Jian decoction may enhance hepatic differentiation of bone marrow‑derived mesenchymal stem cells via SDF‑1 in vitro.

Authors:  Lin-Lin Fu; Bing-Yao Pang; Ying Zhu; Ling Wang; Ai-Jing Leng; Hai-Long Chen
Journal:  Mol Med Rep       Date:  2017-06-29       Impact factor: 2.952

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.